T细胞表位DNA疫苗初免-全病毒灭活疫苗加强可有效保护猪抗pH1N1攻击
结果显示EPITOPE-INACT组肺病变评分降低、肺组织未检出IAV抗原,提示该初免-加强策略对同亚型攻击有效。
要点
- EPITOPE-INACT初免-加强组所有猪在攻击后第5天IAV血清阳性。
- EPITOPE-INACT组肺宏观病变评分降低,肺组织未检出IAV抗原。
- INACT-INACT组病变评分呈低分与高分双峰分布,类似未免疫攻击猪。
核心结论
- 表位驱动DNA疫苗初免后接灭活全病毒疫苗加强的异源初免-加强策略对同亚型pH1N1攻击有效。
研究设计与样本
- 4周龄和7周龄接种,9周龄pH1N1攻击,攻击后第5天剖检。
主要发现
- 攻击时所有INACT-INACT-IAV猪及至攻击后第5天所有EPITOPE-INACT-IAV猪IAV血清阳性。
- EPITOPE-INACT-IAV猪针对疫苗表位肽和pH1N1攻击病毒的IFNγ分泌细胞在攻击时最高。
- EPITOPE-INACT-IAV组所有猪肺宏观病变评分降低。
- 剖检时EPITOPE-INACT-IAV组肺组织未检出IAV抗原,与未免疫未攻击猪相似,不同于其他所有攻击组。
临床怎么用
- 该初免-加强策略值得进一步探索作为异亚型IAV感染的实际防控措施。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Influenza A virus (IAV) vaccines in pigs generally provide homosubtypic protection but fail to prevent heterologous infections. In this pilot study, the efficacy of an intradermal pDNA vaccine composed of conserved SLA class I and class II T cell epitopes (EPITOPE) against a homosubtypic challenge was compared to an intramuscular commercial inactivated whole virus vaccine (INACT) and a heterologous prime boost approach using both vaccines. Thirty-nine IAV-free, 3-week-old pigs were randomly assigned to one of five groups including NEG-CONTROL (unvaccinated, sham-challenged), INACT-INACT-IAV (vaccinated with FluSure XP® at 4 and 7 weeks, pH1N1 challenged), EPITOPE-INACT-IAV (vaccinated with PigMatrix EDV at 4 and FluSure XP® at 7 weeks, pH1N1 challenged), EPITOPE-EPITOPE-IAV (vaccinated with PigMatrix EDV at 4 and 7 weeks, pH1N1 challenged), and a POS-CONTROL group (unvaccinated, pH1N1 challenged). The challenge was done at 9 weeks of age and pigs were necropsied at day post challenge (dpc) 5. At the time of challenge, all INACT-INACT-IAV pigs, and by dpc 5 all EPITOPE-INACT-IAV pigs were IAV seropositive. IFNγ secreting cells, recognizing vaccine epitope-specific peptides and pH1N1 challenge virus were highest in the EPITOPE-INACT-IAV pigs at challenge. Macroscopic lung lesion scores were reduced in all EPITOPE-INACT-IAV pigs while INACT-INACT-IAV pigs exhibited a bimodal distribution of low and high scores akin to naïve challenged animals. No IAV antigen in lung tissues was detected at necropsy in the EPITOPE-INACT-IAV group, which was similar to naïve unchallenged pigs and different from all other challenged groups. Results suggest that the heterologous prime boost approach using an epitope-driven DNA vaccine followed by an inactivated vaccine was effective against a homosubtypic challenge, and further exploration of this vaccine approach as a practical control measure against heterosubtypic IAV infections is warranted.
引用
- Hewitt JS, Karuppannan AK, Tan S, et al. A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model. Vaccine. 2019. PMID: 31248687. doi:10.1016/j.vaccine.2019.06.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。